NASDAQ:VNDA - Vanda Pharmaceuticals Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $18.27 -0.02 (-0.11 %) (As of 03/18/2019 02:49 PM ET)Previous Close$18.29Today's Range$18.23 - $18.7152-Week Range$13.88 - $33.44Volume13,752 shsAverage Volume1.02 million shsMarket Capitalization$961.79 millionP/E Ratio38.27Dividend YieldN/ABeta0.53 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Vanda Pharmaceuticals (NASDAQ:VNDA) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.9 Wall Street analysts have issued ratings and price targets for Vanda Pharmaceuticals in the last 12 months. Their average twelve-month price target is $36.00, suggesting that the stock has a possible upside of 97.04%. The high price target for VNDA is $52.00 and the low price target for VNDA is $21.00. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldBuyBuyConsensus Rating Score: 2.442.442.672.86Ratings Breakdown: 1 Sell Rating(s)3 Hold Rating(s)5 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)3 Hold Rating(s)5 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)3 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)1 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $36.00$36.00$40.1429$25.8571Price Target Upside: 97.04% upside78.93% upside52.98% upside39.77% upsideVanda Pharmaceuticals (NASDAQ:VNDA) Consensus Price Target History Vanda Pharmaceuticals (NASDAQ:VNDA) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails2/14/2019OppenheimerLower Price Target$29.00 ➝ $21.00High2/14/2019Stifel NicolausReiterated RatingBuy$40.00Low2/14/2019Cantor FitzgeraldReiterated RatingHold ➝ Reduce$26.00High12/11/2018CIBCReiterated RatingOutperform ➝ Market PerformLow12/11/2018UBS GroupDowngradeOutperform ➝ Market PerformMedium12/7/2018CitigroupBoost Price TargetBuy ➝ Buy$31.00 ➝ $47.00Medium12/6/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$36.00 ➝ $52.00Low12/4/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$30.00 ➝ $40.00High8/2/2018Seaport Global SecuritiesReiterated RatingBuy$26.00Medium10/19/2017Piper Jaffray CompaniesSet Price TargetBuy$26.00N/A8/3/2017HC WainwrightSet Price TargetBuy$18.00High(Data available from 3/18/2017 forward) This page was last updated on 3/18/2019 by MarketBeat.com StaffFeatured Article: What economic reports are most valuable to investors?